Epidemiology and Etiology



Endometrial carcinoma is also called corpus cancer. During the past 20 years there has been a drastic increase in the worldwide incidence of endometrial carcinoma, such that in many areas endometrial carcinoma is now ranked as the second or third most common malignant neoplasm of the female genital tract. The reported incidence varies according to country, area, and race. According to the International Agency for Research on Cancer (1982), incidence rates are especially high in North America and northern Europe and are low in Central America and Asia (Fig. 1.1). The American Cancer Society reported that approximately 37000 women would develop endometrial carcinoma in 1979. Therefore, this lesion is seen over twice as frequently as carcinoma of the ovary and cervix (Cancer Statistics 1979). Masubuchi et al. (1975) reported 1958 patients with endometrial carcinoma and 38080 patients with cervical cancer during the 12 years from 1961 to 1972, based on records collected from 33 university hospitals and cancer centers in Japan, giving a ratio of the incidence of endometrial carcinoma to cervical cancer of 1:19.5. In the United States, the ratio of the incidence of endometrial carcinoma to cervical cancer was reported to be 1:2 during the period 1969–1970 (Duun 1974).


Cervical Cancer Postmenopausal Woman Endometrial Cancer Obstet Gynecol Endometrial Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ackerman GE, Smith ME, Mendelson CR et al. (1981) Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J Clin Endocrinol Metab 53:412–417PubMedGoogle Scholar
  2. Algard FT, Montessori GA, Van Netten JP, Munn M (1978) Is there a high-affinity estrogen binder in human serum? Clin Chem 24:1848–1849PubMedGoogle Scholar
  3. Armstrong B (1982) Endocrine factors in human carcinogenesis. In: Bartsch H, Armstrong B (eds) Host factors in human carcinogenesis. IARC Lyon, p 193–221Google Scholar
  4. Austin DE, Roe KM (1979) Increase in cancer of the corpus uteri in the San Francisco- Oakland standard metropolitan statistical area, 1960–1975. JNCI 62:13–16PubMedGoogle Scholar
  5. Barlow JJ, Emerson K, Saxena BN (1969) Estradiol production after ovariectomy of carcinoma of the breast. Relevance to the treatment of menopausal women. N Engl J Med 280:633–637PubMedGoogle Scholar
  6. Bird Ch E, Green RN, Clark AF (1969) Effect of the administration of estrogen on the disappearance of 3H-testosterone in the plasma of human subjects. J Clin Endocrinol Metab 29:123–126PubMedGoogle Scholar
  7. Boström H, Wengle B (1967) Studies on ester sulfates 23. Distribution of phenol and steroid sulphokinase in adult human tissues. Acta Endocrinol 56:691–704PubMedGoogle Scholar
  8. Brown JB, Smyth BJ (1971) Oestrone sulfate - the major circulating oestrogen in the normal menstrual cycle. J Reprod Fertil 24:142PubMedGoogle Scholar
  9. Buirchell BJ, Hähnell R (1975) Metabolism of estradiol-17β in human endometrium during the menstrual cycle. J Steroid Biochem 6:1489PubMedGoogle Scholar
  10. Burke CW, Anderson DC (1972) Sex-hormone-binding-globulin is an oestrogen amplifier. Nature 240:38–40PubMedGoogle Scholar
  11. Cancer Statistics (1979) CA Cancer J Clin 29:6Google Scholar
  12. Cariström K, Sköldefors H (1977) Determination of total oestrone in peripheral serum from nonpregnant humans. J Steroid Biochem 8:1127–1128Google Scholar
  13. Crissman JD, Azoury RS, Barnes AE, Schelhas HF (1981) Endometrial cancer in women 40 years of age or younger. Obstet Gynecol 57:699–704PubMedGoogle Scholar
  14. Damon A (1960) Host factors in cancer of the breast and uterine cervix and corpus. JNCI 24:483–516PubMedGoogle Scholar
  15. Davidson BJ, Gambone JC, LaGasse LD et al. (1981) Free estradiol in postmenopausal women with and without endometrial cancer. J Clin Endocrinol Metab 52:404–408PubMedGoogle Scholar
  16. De Moor P, Hayns W, Bouillion R (1972) Growth hormone and the steroid binding β-globulin of human plasma. J Steroid Biochem 3:593–600PubMedGoogle Scholar
  17. Dennis M, Horst HJ, Krieg M, Voigt KD (1977) Plasma sex hormone-binding globulin binding capacity in benign prostatic hypertrophy and prostatic carcinoma: comparison with an age dependent rise in normal human males. Acta Endocrinol 84:207–214PubMedGoogle Scholar
  18. Duignan NM (1976) Polycystic ovarian disease. Br J Obstet Gynaecol 83:593–602PubMedGoogle Scholar
  19. Duun J (1974) Geographic consideration of endometrial cancer. Gynecol Oncol 2:114–121Google Scholar
  20. Egloff M, Vranckx R, Tardivel-Lacombe J, Degrelle H (1981) Immunochemical characterization and quantitation of human sex steroid binding plasma protein. Steroids 37:455–462PubMedGoogle Scholar
  21. Elwood JM, Cole P, Rothman KJ, Kaplan SD (1977) Epidemiology of endometrial cancer. JNCI 59:1055–1060PubMedGoogle Scholar
  22. Feckner RF, Kaufman RH (1974) Endometrial adenocarcinoma in Stein-Leventhal syndrome. Cancer 34:444–452Google Scholar
  23. Fex G, Adielsson G, Mattson W (1981) Oestrogen-like effects of tamoxifen on the concentration of proteins in plasma. Acta Endocrinol 97:109–113PubMedGoogle Scholar
  24. Fishman J, Bradlow HL, Gallagher RF (1960) Oxidative metabolism of estradiol. J Biol Chem 235:3104PubMedGoogle Scholar
  25. Forney JP, Milewich L, Chen GT et al. (1981) Aromatization of androstenedione to estrone by human adipose tissue in vitro. Correlation with adipose tissue mass, age, and endometrial neoplasia. J Clin Endocrinol Metab 53:192–199PubMedGoogle Scholar
  26. Fox H, Sen DR (1970) A continued study of the constitutional stigmata of endometrial adenocarcinoma. Br J Cancer 240:30–36Google Scholar
  27. Frick HC, Munnell EW, Richart RM et al. (1973) Carcinoma of endometrium. Am J Obstet Gynecol 115:663–676PubMedGoogle Scholar
  28. Gray LA, Christopherson WM, Hoover RN (1977) Estrogen and endometrial carcinoma. Obstet Gynecol 49:385–389PubMedGoogle Scholar
  29. Greenblatt RB, Colle ML, Mahesh VB (1976) Ovarian and adrenal steroid production in the postmenopausal women. Obstet Gynecol 47:383–387PubMedGoogle Scholar
  30. Greenblatt RB, Stoddard LD (1978) The estrogen-cancer controversy. J Am Geriatr Soc 26:1–8PubMedGoogle Scholar
  31. Greene JW (1957) Feminizing mesenchymoma with associated endometrial carcinoma. Am J Obstet Gynecol 74:31PubMedGoogle Scholar
  32. Grodin JM, Siiteri PK, MacDonald PC (1973) Source of estrogens production in postmenopausal women. J Clin Endocrinol Metab 36:207–214PubMedGoogle Scholar
  33. Gurpide E, Angers M, Vande Weile R, Lieberman S (1962) Determination of secretory rates of estrogens in pregnant and nonpregnant women from the specific activities of urinary metabolites. J Clin Endocrinol Metab 22:935–945PubMedGoogle Scholar
  34. Gurpide E, Gusberg SB, Tseng L (1976) Estradiol binding and metabolism in human endometrial hyperplasia and adenocarcinoma. J Steroid Biochem 7:891–896PubMedGoogle Scholar
  35. Gurpide E (1978a) Metabolic influences on the action of estrogens: therapeutic applications. Pediatrics (Suppl) 62:1114–1120PubMedGoogle Scholar
  36. Gurpide E (1978b) Enzymatic modulation of hormonal action at the target tissue. J Toxicol Environ Health 4:249–268PubMedGoogle Scholar
  37. Gurpide E, Marks C (1981) Influence of endometrial 17β-hydroxysteroid dehydrogenase activity on the binding of estradiol to receptors. J Clin Endocrinol Metab 52:252–255PubMedGoogle Scholar
  38. Gusberg SB, Kardon P (1971) Proliferative endometrial response to theca-granulosa cell tumors. Am J Obstet Gynecol 111:633–643PubMedGoogle Scholar
  39. Hammond GL, Nisker JA, Jones LA, Siiteri PK (1980) Estimation of the percent free steroid in undiluted serum by centrifugal ultrafiltration-dialysis. J Biol Chem 255:5023–5026PubMedGoogle Scholar
  40. Husslein H, Breitenecker G, Tatra G (1978) Premalignant and malignant uterine changes in immunosuppressed renen transplant recipients. Acta Obstet Gynecol Scand 57:73–78PubMedGoogle Scholar
  41. Hawkins RA, Oakey RE (1974) Estimation of oestrone sulfate, oestradiol-17β and oestrone in peripheral plasma: concentrations during the menstrual cycle and in men. J Endocrinol 60:3–17PubMedGoogle Scholar
  42. Hobkirk R, Mellor JD, Nilson M (1975) In vitro metabolism of 17β-estradiol in human liver tissue. Can J Biochem 53:903–906PubMedGoogle Scholar
  43. Horwitz RI, Feinstein AR (1978) Alternative analytic methods for case-control studies of estrogens and endometrial cancer. N Engl J Med 299:1089–1094PubMedGoogle Scholar
  44. IARC, International Agency for Research on Cancer (1982) Caner incidence in five continents, vol IV. IARC Sci Publ 42Google Scholar
  45. Jackson RL, Dockerty MB (1957) The Stein-Leventhal syndrome. Am J Obstet Gynecol 73:161–173PubMedGoogle Scholar
  46. James VHT, Tunbridge RDG, Wilson GA et al. (1978) In: James VHT, Serio M, Giusti G (eds) The endocrine function of the human adrenal cortex. Academic, New York, p 179Google Scholar
  47. Judd HL, Judd GE, Lucas WE, Yen SSC (1974) Endocrine function of the postmenopausal ovary: concentrations of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab 39:1020–1024PubMedGoogle Scholar
  48. Judd HL, Davidson BJ, Frumar AM et al. (1980) Serum androgens and estrogens in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol 136:859–871PubMedGoogle Scholar
  49. Kley HK, Herman J, Morgner KD, Krüskemper HL (1973) Effects of testosterone oenanthate on plasma concentrations of thyroxine, cortisol, testosterone and hormone binding proteins in patients with hypogonadism. Horm Metab Res 5:271–274PubMedGoogle Scholar
  50. Lang JH, Wu BZ, Tang HY (1978) Endometrial carcinoma: a clinico-pathologic analysis of 108 cases. J Chin Obstet Gynecol 13:6–12Google Scholar
  51. Li SY (1988) Epidemiology and etiology. In: Li SY (ed) Endometrial carcinoma. People’s Medical Publishing House, Beijing, p 1–25Google Scholar
  52. Longcope C (1971) Metabolic clearance and blood production rate of estrogens in postmenopausal women. Am J Obstet Gynecol 111:778–781PubMedGoogle Scholar
  53. Longcope C, Pratt JH, Schneider SH, Fineberg SE (1976) In vitro studies on the metabolism of estrogens by muscle and adipose tissue of normal males. J Clin Endocrinol Metab 43:1134–1145PubMedGoogle Scholar
  54. Longcope C, Pratt JH, Schneider SH, Fineberg SE (1978) Aromatization of androgens by muscle and adipose tissue in vivo. J Clin Endocrinol Metab 46:146–152PubMedGoogle Scholar
  55. Loriaux DL, Ruder HJ, Lipsett MB (1971) The measurement of estrone sulfate in plasma. Steroids 18:463PubMedGoogle Scholar
  56. MacDonald PC, Edman CD, Hemsell DL et al. (1978) The effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol 130:448–455PubMedGoogle Scholar
  57. Mack TM, Pike MC, Henderson BE et al. (1976) Estrogens and endometrial cancer in a retirement community. N Engl J Med 294:1262–1267PubMedGoogle Scholar
  58. MacMahon B (1974) Risk factors for endometrial cancer. Gynecol Oncol 2:122–129PubMedGoogle Scholar
  59. Mansell M, Hertig AT (1955) Granulosa-theca cell tumors and endometrial carcinoma. A study of their relationship and a survey of 80 cases. Obstet Gynecol 6:385PubMedGoogle Scholar
  60. Masubuchi K, Nemoto H (1972) Epidemiologic studies on uterine cancer at Cancer Institute (Hospital), Tokyo, Cancer 30:268 – 275PubMedGoogle Scholar
  61. Masubuchi K, Nemoto H, Masubuchi S Jr et al. (1975) Increasing incidence of endometrial carcinoma in Japan. Gynecol Oncol 3:335–346PubMedGoogle Scholar
  62. Mattingly RF (1985) Malignant tumors of the uterus. In: Mattingly RF, Thompson JD Telinde’s operative gynecology, 6th edn. Lippincott, Philadelphia, 845–876Google Scholar
  63. McCarty KS Jr, Barton TK, Peete CH Jr et al. (1978) Gonadal dysgenesis with adenocarcinoma of the endometrium. An electron-microscopic and steroid receptor analysis with a review of the literature. Cancer 42:512–520PubMedGoogle Scholar
  64. McDonald TW, Malkasian GD, Gaffcy TA (1977a) Endometrial cancer associated with feminizing tumor and polycystic ovarian disease. Obstet Gynecol 49:654–658PubMedGoogle Scholar
  65. McDonald TW, Annegers JF, O’Fallen WM et al. (1977b) Exogenous estrogen and endometrial carcinoma: case control and incidence study. Am J Obstet Gynecol 127:572–580PubMedGoogle Scholar
  66. Mercier C, Alfsen A, Baulieu EE (1965) Proceedings second symposium on steroid hormones, GhentGoogle Scholar
  67. Nimrod A, Ryan KJ (1975) Aromatization of androgens by human abdominal and breast fat tissue. J Clin Endocrinol Metab 40:367–372PubMedGoogle Scholar
  68. Nisker JA, Hammond GL, Davidson BJ et al. (1980) Serum sex hormone binding globulin capacity and the percentage of free estradiol in postmenopausal women with and without endometrial carcinoma. Am J Obstet Gynecol 138:637–642PubMedGoogle Scholar
  69. Norris HJ, Taylor HB (1968) Prognosis of granulosa-thecal tumor of the ovary. Cancer 21:255–263PubMedGoogle Scholar
  70. Novak E, Yui E (1936) Relation of endometrial by hyperplasia to adenocarcinoma of the uterus. Am J Obstet Gynecol 32:674Google Scholar
  71. Nunez M, Aedo AR, Landgren BM et al. (1977) Studies on the pattern of circulating steroids in the normal menstrual cycle, 6. Levels of oestrone sulphate and oestradiol sulphate. Acta Endocrinol 86:621–633PubMedGoogle Scholar
  72. O’Brien TJ, Higashi M, Kanasugi H et al. (1982) A plasma serum estrogen-binding protein distinct from testosterone-estradiol-binding globulin. J Clin Endocrinol Metab 54:793–797PubMedGoogle Scholar
  73. O’Dea JP, Wieland RG, Hallberg MC et al. (1979) Effect of dietary weight loss on sex steroid binding, sex steroids, and gonadotropins in obese postmenopausal women. J Lab Clin Med 93:1004–1008PubMedGoogle Scholar
  74. Ostor AG, Fortune DW, Evans JH et al. (1978) Endometrial carcinoma in gonadal dysgenesis with and without estrogen therapy. Gynecol Oncol 6:316–327PubMedGoogle Scholar
  75. Pack BA, Tovar R, Booth E, Brooks SC (1979) The cyclic relationship of estrogen sulfurylation to the nuclear receptor level in human endometrial curettings. J Clin Endocrinol Metab 48:420–424PubMedGoogle Scholar
  76. Pardridge WM, Mietus LJ, Frumar AM et al. (1980) Inverse relationship between the sex hormone binding globulin level of human serum and the unidirectional clearance of testosterone and estradiol by rat brain. Am J Physiol 263:103–108Google Scholar
  77. Payne AH, Lawrence CC, Foster DL, Jaffe RB (1973) Intranuclear binding of 17β-estradiol and estrone in female ovine pituitaries following incubation with oestrone sulfate. J Biol Chem 248:1598–1602PubMedGoogle Scholar
  78. Perel E, Killinger DW (1979) The interconversion and aromatization of androgens by human adipose tissue. J Steroid Biochem 10:623–627PubMedGoogle Scholar
  79. Raynaud JP, Mercier-Bodard C, Baulieu EE (1971) Rat estradiol binding plasma protein (EBP). Steroids 18:767PubMedGoogle Scholar
  80. Riskallah TH, Tovell HMM, Kelly WG (1975) Production of estrone and fractional conversion of circulating androstenedione to estrone in women with endometrial carcinoma. J Clin Endocrinol Metab 40:1045–1056Google Scholar
  81. Roberts KD, Rochefort JG, Bleau G, Chapdelaine A (1980) Plasma estrone sulfate levels in postmenopausal women. Steroids 35:179–187PubMedGoogle Scholar
  82. Rodriquez J, Hart WR (1982) Endometrial cancers occurring 10 or more years after pelvic irradiation for carcinoma. Int J Gynecol Pathol 1:135–144Google Scholar
  83. Rosenfield RL (1971) Plasma testosterone binding globulin and indexes of the concentration of unbound plasma androgens in normal and hirsute subjects. J Clin Endocrinol Metab 32:717PubMedGoogle Scholar
  84. Rosenthal HE, Pietrazak E, Slaunwhite WR Jr, Sandberg A A (1972) Bonding of estrone sulfate in human plasma. J Clin Endocrinol Metab 34:805PubMedGoogle Scholar
  85. Rosner WA (1972) A simplified method for the quantitative determination of testoster- one-estradiol binding globulin activity in human plasma. J Clin Endocrinol Metab 34:983PubMedGoogle Scholar
  86. Puder H, Corvol P, Mahoudeau JA et al. (1971) Effects of induced hyperthyrodism on steroid metabolism in man. J Clin Endocrinol Metab 33:382–387Google Scholar
  87. Ruder HJ, Loriaux L, Lipsett MB (1972) Estrone sulfate: production rate and metabolism in man. J Clin Invest 51:1020–1033PubMedGoogle Scholar
  88. Saez JM, Morera AM, Dazord A, Bertrand J (1972) Adrenal and testicular contribution to plasma estrogens. J Endocrinol 55:41–47PubMedGoogle Scholar
  89. Sakai F, Cheix F, Clavel M et al. (1978) Increases in steroid binding globulin induced by tamoxifen in patients with carcinoma of the breast. J Endocrinol 76:219–226PubMedGoogle Scholar
  90. Samoljik E, Santen RJ, Wells SA (1977) Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels. J Clin Endocrinol Metab 45:480–487Google Scholar
  91. Schindler AE, Ebert A, Fiedrick E (1972) Conversion of androstenedione to estrone by human fat tissue. J Clin Endocrinol Metab 35:627–630PubMedGoogle Scholar
  92. Scully R (1982) Definition of endometrial carcinoma precursors. Clin Obstet Gynaecol 25:39–48Google Scholar
  93. Siiteri PK, MacDonald PC (1973) Role of extraglandular estrogen in human endocrinology, In: Greep RD, Atswood EB (eds) Handbook of physiology, vol II. Williams and Wilkins, Baltimore, p 615–628Google Scholar
  94. Silverberg SG, Makowski EL (1975) Endometrial carcinoma in young women taking oral contraceptive agents. Obstet Gynecol 46:503–506PubMedGoogle Scholar
  95. Tisman G, Wu SJG (1976) Oestrogen-binding protein in blood to predict response of breast cancer to hormone manipulation. Lancet 2:145–146PubMedGoogle Scholar
  96. Tseng L, Gurpide E (1975a) Induction of human endometrial estradiol dehydrogenase by progestins. Endocrinology 97:825–833PubMedGoogle Scholar
  97. Tseng L, Gurpide E (1975b) Effects of progestin on estradiol receptor levels in human endometrium. J Clin Endocrinol Metab 41:402–404PubMedGoogle Scholar
  98. Tseng L, Liu CL (1981) Stimulation of arylsulfatransferase activity by progestins in human endometrium in vitro. J Clin Endocrinol Metab 53:418–421PubMedGoogle Scholar
  99. Van Nagell JR Jr, Roddick JW, Wallace JO (1972) Clinical correlates of endometrial carcinoma. Am J Obstet Gynecol 112:935–937PubMedGoogle Scholar
  100. Vermeulen A, Verdonck L, Van der Straeten M, Orie N (1969) Capacity of the testosterone-binding globulin in human plasma and influence of specific binding of testosterone on its metabolic clearance rate. J Clin Endocrinol Metab 29:1470–1480Google Scholar
  101. Vermeulen A (1976) The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab 42:247–253PubMedGoogle Scholar
  102. Vermeulen A, Verdonck L (1978) Sex hormone concentrations in postmenopausal women. Clin Endocrinol 9:59–66Google Scholar
  103. Waard F de, Oettle AG (1965) A cytological survey of postmenopausal estrus in Africa. Cancer 18:450–459Google Scholar
  104. Waard F de (1982) Uterine corpus. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention. Saunders, Philadelphia, p 901–908Google Scholar
  105. Weinstein IB (1982) Carcinogenesis as a multistage process-experimental evidence. In: Bartsch H, Armstrong B (eds) Host factors in human carcinogenesis. IARC, Lyon, p 9–25Google Scholar
  106. Weiss NS, Szekely DR, Austin DF (1976) Increasing incidence of endometrial cancer in the United States. N Engl J Med 294:1259–1262PubMedGoogle Scholar
  107. Weiss NS, Sayvetz TA (1980) Incidence of endometrial cancer in relation to the use of oral contraceptives. N Engl J Med 302:551–554PubMedGoogle Scholar
  108. Westphal U (1971) Steroid-protein interactions. Springer, Berlin Heidelberg, New York (Monographs on endocrinology, vol 4)Google Scholar
  109. Wright K, Collins DC, Musey PI, Preedy JRK (1978) Specific radioimmunoassay for estrone sulfate in plasma and urine without hydrolysis. J Clin Endocrinol Metab 47:1092–1098PubMedGoogle Scholar
  110. Wu BZ, Tang MY, Lang JH (1982) Endometrial carcinoma. In: Lin QZ (ed) Gynecologic oncology. People’s Medical, Beijing, China p 85–104Google Scholar
  111. Wynder EL, Escher GC, Mantel N (1966) An epidemiological investigation of cancer of the endometrium. Cancer 19:489–520PubMedGoogle Scholar
  112. Ziel HK, Finkle WD (1975) Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 293:1167–1170PubMedGoogle Scholar

Copyright information

© The People’s Medical Publishing House Beijing and Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  1. 1.Gynecologic Oncology DepartmentCancer Institute (Hospital) Chinese Academy of Medical SciencesBeijingP.R.China

Personalised recommendations